Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (7081)	9/22/1999 11:24:00 PM
From: WTDEC	Read Replies (1) \| Respond to of 9719

Good news on CGPI. Wonder if it will drift back as low as 13. -------------------------------------------------------------------------------- Wednesday September 22, 9:14 pm Eastern Time Company Press Release SOURCE: Merck & Co., Inc. CollaGenex to Co-Promote Merck's Medicine Vioxx(R) to Dentists WEST POINT, Pa., Sept. 22 /PRNewswire/ -- Merck & Co., Inc. (NYSE: MRK - news) and CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI - news) have entered into an agreement under which CollaGenex will co-promote Vioxx© (rofecoxib) to dentists, periodontists and oral surgeons in the United States.<SNIP> I can add that as a Periostat patient, the drug seems to be helping... Best regards and thanks for all your thoughtful posts. Walter